Renaissance Technologies’s Arena Pharmaceuticals Inc ARNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-181,516
| Closed | -$16.9M | – | 4635 |
|
|
2021
Q4 | $16.9M | Buy |
+181,516
| New | +$12M | 0.02% | 800 |
|
|
2019
Q3 | – | Sell |
-32,816
| Closed | -$1.92M | – | 3822 |
|
|
2019
Q2 | $1.92M | Buy |
+32,816
| New | +$1.7M | ﹤0.01% | 2345 |
|
|
2019
Q1 | – | Sell |
-52,368
| Closed | -$2.04M | – | 3787 |
|
|
2018
Q4 | $2.04M | Buy |
+52,368
| New | +$2.06M | ﹤0.01% | 2217 |
|
|
2018
Q2 | – | Sell |
-235,550
| Closed | -$9.3M | – | 3629 |
|
|
2018
Q1 | $9.3M | Sell |
235,550
-330,100
| -58% | -$12.8M | 0.01% | 1412 |
|
|
2017
Q4 | $19.2M | Sell |
565,650
-329,516
| -37% | -$9.39M | 0.02% | 961 |
|
|
2017
Q3 | $22.8M | Buy |
895,166
+25,800
| +3% | +$592K | 0.03% | 815 |
|
|
2017
Q2 | $14.7M | Buy |
869,366
+21,421
| +3% | +$294K | 0.02% | 1030 |
|
|
2017
Q1 | $12.4M | Buy |
847,945
+95,719
| +13% | +$1.42M | 0.02% | 1101 |
|
|
2016
Q4 | $10.7M | Buy |
752,226
+58,576
| +8% | +$907K | 0.02% | 1185 |
|
|
2016
Q3 | $12.1M | Buy |
693,650
+133,514
| +24% | +$2.21M | 0.02% | 1028 |
|
|
2016
Q2 | $9.58M | Buy |
560,136
+117,750
| +27% | +$2.1M | 0.02% | 1176 |
|
|
2016
Q1 | $8.71M | Buy |
442,386
+129,466
| +41% | +$2.08M | 0.02% | 1237 |
|
|
2015
Q4 | $5.95M | Buy |
312,920
+102,700
| +49% | +$2.09M | 0.01% | 1355 |
|
|
2015
Q3 | $4.01M | Buy |
210,220
+43,540
| +26% | +$1.48M | 0.01% | 1537 |
|
|
2015
Q2 | $7.73M | Buy |
166,680
+74,200
| +80% | +$3.22M | 0.02% | 1134 |
|
|
2015
Q1 | $4.04M | Buy |
92,480
+69,430
| +301% | +$3.23M | 0.01% | 1499 |
|
|
2014
Q4 | $800K | Sell |
23,050
-54,266
| -70% | -$2.2M | ﹤0.01% | 2241 |
|
|
2014
Q3 | $3.24M | Buy |
77,316
+71,580
| +1,248% | +$3.2M | 0.01% | 1400 |
|
|
2014
Q2 | $336K | Buy |
+5,736
| New | +$361K | ﹤0.01% | 2446 |
|
Renaissance Technologies's ARNA Position: Q1 2022 in Review
Renaissance Technologies sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 181,516 shares — an estimated $16.9M sold.
Renaissance Technologies first reported a position in ARNA in Q2 2014 and held it in 19 quarters. The position peaked at $22.8M in Q3 2017. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.
- Renaissance Technologies reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
- Renaissance Technologies sold 181,516 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $16.9M.
- Renaissance Technologies first reported a position in Arena Pharmaceuticals Inc in Q2 2014 and held it in 19 quarters.
- Renaissance Technologies's Arena Pharmaceuticals Inc position peaked at $22.8M in Q3 2017.
- 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.
Based on Renaissance Technologies's 13F filing for Q1 2022, filed 13 May 2022.